Back Quantitative

Quant Market in Numbers: Another Round of Increased Mean Reversal

Published on March 18, 2024

∙ Download the PDF Report

By

Dennis DeBusschere

Brian Herlihy

Sophia Wang

Kevin Brocks

Stronger than expected CPI and PPI readings last week led to increased policy uncertainty. The S&P dropped on the data and risk-off internals rallied, reversing some of the risk-on gains from the first week of March. Value has been the leading factor for March though, adding to the month over month factor reversal.

The long side of the factor reversal portfolio increased due to Value and Low Volatility returns improving. On the short side, Earnings Growth has underperformed, reversing sharply from February. The biggest story is the weakening of Momentum. High price momentum names are not underperforming significantly, but returns to the factor have reversed from it rapid gain in Feb. As we discussed (HERE), Momentum headwinds have increased, making some reversal more likely. Over the past week Value continued to gain even amid the risk-off general rotation.

A graph of a graph of a graph of a graph of a graph of a graph of a graph of a graph of a graph of a graph of a graph of a graph of a graph of

Description automatically generated

GARP overall has rebounded since February and remains our preferred screening approach while the inflation/growth outlooks are uncertain. Value has been the incremental support for GARP during the recent rebound basket and the portfolio rebound sharply since late February. We continue to favor GARP names expecting Value names to gain to catch up with its return divergence with yield moves.

Interestingly, though indexed factor and industry group mean reversal portfolios trend to diverge, their monthly returns move together with correlation of ~58%. Applying portfolio returns as a proxy for mean reversal, the yield curve has a more consistent negative correlation with both industry and factor mean reversal portfolios – a steepening curve encourages trends. Easing of financial conditions tends to support reversal. If the FOMC does not surprise this week, a steeper curve and stable FCI should be the base case assumption, favoring the current Value trend.

Another Round of Increased Mean Reversal: Stronger than expected CPI and PPI readings last week led to increased policy uncertainty. The S&P dropped on the data and risk-off internals rallied, reversing some of the risk-on gains from the first week of March. Value has been the leading factor for March though, adding to the month over month factor reversal. Our indexed factor mean reversal portfolio (long the worst 4 and short the best 4 factors from the prior month) is climbing again this month.

The long side of the factor reversal portfolio increased due to Value and Low Volatility returns improving. On the short side, Earnings Growth has underperformed, reversing sharply from February. The biggest story is the weakening of Momentum. High price momentum names are not underperforming significantly, but returns to the factor have reversed from it rapid gain in Feb. As we discussed (HERE), Momentum headwinds have increased, making some reversal more likely. Over the past week Value continued to gain even amid the risk-off general rotation.

A graph of a graph of a graph of a graph of a graph of a graph of a graph of a graph of a graph of a graph of a graph of a graph of a graph of

Description automatically generated

GARP overall has rebounded since February and remains our preferred screening approach while the inflation/growth outlooks are uncertain. Value has been the incremental support for GARP during the recent rebound basket and the portfolio rebound sharply since late February. We continue to favor GARP names expecting Value names to gain to catch up with its return divergence with yield moves.

Longer-term, factor mean reversal has NOT been an effective strategy. Its returns are roughly flat over the post-COVID period. That is consistent with higher factor return volatility. Both short-term and long-term factor volatility have above pre-COVID levels and the current reading remains above its median as well. Both the factor portfolio returns and volatility suggest increasing rotations within factors post-COVID.

A graph of a graph with numbers and lines

Description automatically generated with medium confidence

Mean reversal at the industry group level has been VERY strong. The industry group mean reversal portfolio (long the worst quartile industry group and short the best quartile industry group prior month) gained 1.5% in March. Historically, industry mean reversal is a more effective strategy, gaining in most non-recessionary periods.

A graph of orange and blue lines

Description automatically generated

Interestingly, though indexed factor and industry group mean reversal portfolios trend to diverge, their monthly returns move together with correlation of ~58%. Applying portfolio returns as a proxy for mean reversal, the yield curve has a more consistent negative correlation with both industry and factor mean reversal portfolios – a steepening curve encourages trends. Easing of financial conditions tends to support reversal. If the FOMC does not surprise this week, a steeper curve and stable FCI should be the base case assumption, favoring the current Value trend.

A screen shot of a graph

Description automatically generated

Though both the yield curve and mean reversal portfolio returns are volatile, their negative correlation suggests steeper curves should help lower market mean reversal, which is expected to happen as 10yr yield to climb on expanding economy and 3mo rate dropping.

A graph of blue and orange lines

Description automatically generated

DISCLOSURES AND DISCLAIMERS

Analyst Certification

The analyst, 22V Research Group, primarily responsible for the preparation of this research report attests to the following: (1) that the views and opinions rendered in this research report reflect his or her personal views about the subject companies or issuers; and (2) that no part of the research analyst’s compensation was, is, or will be directly related to the specific recommendations or views in this research report.

Analyst Certifications and Independence of Research.

Each of the 22V Research analysts whose names appear on the front page of this report hereby certify that all the views expressed in this Report accurately reflect our personal views about any and all of the subject securities or issuers and that no part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views of in this Report.

22V Research (the “Company”) is an independent research provider. The Company is not a member of the FINRA or the SIPC and is not a registered broker dealer or investment adviser. 22V Research has no other regulated or unregulated business activities which conflict with its provision of independent research.

22V Research, LLC is a professional services and independent publication organization. 22V Research, LLC is not a securities broker-dealer, not a member of the Financial Industry Regulatory Authority (FINRA), not a registered investment advisor (RIA) and not a member of SIPC.

Securities transactions, when offered, are offered by 22V Securities, LLC through LPS Capital, LLC. Certain employees of 22V Securities, LLC are dually registered as securities representatives of LPS Capital, LLC or Analyst Hub Securities, LLC. 22V Securities, LPS Capital and Analyst Hub Securities are members FINRA, SIPC.

https://brokercheck.finra.org/

Current Ratings Definition.

SECTOR OUTPERFORM: An “outperform” rating anticipates the company will outperform the S&P Regional Banking Index (peer group).

SECTOR PERFORM: A “market perform” rating anticipates the company will perform in line with the S&P Regional Banking Index (peer group).

SECTOR UNDERPERFORM: An “underperform” rating anticipates the company will underperform the S&P Regional Banking Index (peer group).

Limitation Of Research And Information.

This Report has been prepared for distribution to only qualified institutional or professional clients of 22V Research Group. The contents of this Report represent the views, opinions, and analyses of its authors. The information contained herein does not constitute financial, legal, tax or any other advice. All third-party data presented herein were obtained from publicly available sources which are believed to be reliable; however, the Company makes no warranty, express or implied, concerning the accuracy or completeness of such information. In no event shall the Company be responsible or liable for the correctness of, or update to, any such material or for any damage or lost opportunities resulting from use of this data. Nothing contained in this Report or any distribution by the Company should be construed as any offer to sell, or any solicitation of an offer to buy, any security or investment. Any research or other material received should not be construed as individualized investment advice. Investment decisions should be made as part of an overall portfolio strategy and you should consult with a professional financial advisor, legal and tax advisor prior to making any investment decision. 22V Research Group shall not be liable for any direct or indirect, incidental or consequential loss or damage (including loss of profits, revenue or goodwill) arising from any investment decisions based on information or research obtained from 22V Research Group.

Reproduction And Distribution Strictly Prohibited.

No user of this Report may reproduce, modify, copy, distribute, sell, resell, transmit, transfer, license, assign or publish the Report itself or any information contained therein. Notwithstanding the foregoing, clients with access to working models are permitted to alter or modify the information contained therein, provided that it is solely for such client’s own use. This Report is not intended to be available or distributed for any purpose that would be deemed unlawful or otherwise prohibited by any local, state, national or international laws or regulations or would otherwise subject the Company to registration or regulation of any kind within such jurisdiction.

Copyrights, Trademarks, Intellectual Property.

22V Research Group, and any logos or marks included in this Report are proprietary materials. The use of such terms and logos and marks without the express written consent of 22V Research Group is strictly prohibited. The copyright in the pages or in the screens of the Report, and in the information and material therein, is proprietary material owned by 22V Research Group unless otherwise indicated. The unauthorized use of any material on this Report may violate numerous statutes, regulations and laws, including, but not limited to, copyright, trademark, trade secret or patent laws.